MyFinsight
Home
Blog
About
Contact
Maturities of marketable
securities
$162,529K
Proceeds from exercise of
common stock options
$1,190K
Net cash provided by
investing activities
$118,952K
Net cash provided by
financing activities
$1,181K
Canceled cashflow
$43,577K
Canceled cashflow
$9K
Net increase in
cash, cash...
$44,963K
Canceled cashflow
$75,170K
Purchases of marketable
securities
$42,610K
Purchases of property and
equipment, net
$967K
Stock-based compensation
$14,536K
Accounts payable
$3,050K
Prepaid expenses and
other assets
-$3,025K
Accrued and other
liabilities
$2,727K
Depreciation and
amortization
$688K
Lease liabilities
$686K
Amortization of right-of-use
assets
$455K
Proceeds from issuance of
common stock related to...
-$9K
Net cash used in
operating activities
-$75,170K
Canceled cashflow
$25,167K
Net loss
-$98,539K
Contract liabilities
-$2,753K
Back
Back
Cash Flow
IDEAYA Biosciences, Inc. (IDYA)
IDEAYA Biosciences, Inc. (IDYA)
source: myfinsight.com